Myers Michael C, Berge Amanda, Zhong Yue, Maruyama Sonomi, Bueno Cindy, Bastien Arnaud, Hofer Kimberly, Kaur Ramandeep, Fazeli Mir Sohail, Golchin Negar
Bristol Myers Squibb, Princeton, NJ, USA.
Evidinno Outcomes Research Inc., Vancouver, BC, Canada.
Cardiol Res. 2025 Jul 8;16(4):295-305. doi: 10.14740/cr2071. eCollection 2025 Aug.
Dilated cardiomyopathy (DCM) is a major contributing factor for heart failure and cardiac transplantation worldwide. Estimating the prevalence and incidence of DCM is critical for understanding the burden of illness in these patients and improving the landscape of preventative treatments. Previous reviews have shown substantial prevalence and incidence estimates for DCM within key regions such as the United States and several European countries. This review aimed to describe the published evidence on the prevalence and incidence of DCM within the United States, France, Germany, Italy, Spain, and the United Kingdom.
MEDLINE and Embase were searched from database inception to May 9, 2023 for English-language studies reporting the prevalence or incidence of DCM within general populations of adults or children in countries of interest. Manual searches of relevant conferences and bibliographies of previous literature reviews were also conducted.
Of 6,145 identified articles, 10 unique studies were included in the review. Six studies reported prevalence, and five studies reported incidence of DCM in various populations. Prevalence estimates of DCM, including idiopathic and non-idiopathic causes, within adults (≥ 18 years) and/or heterogeneous (all ages) populations ranged from 42.8 to 118.3 per 100,000 persons; idiopathic DCM estimates ranged from 8.3 to 59.2 per 100,000 persons. Prevalence of adolescent (about 11 - 18 years) DCM, including idiopathic and non-idiopathic causes, ranged from 2.6 to 212.8 per 100,000 persons. Annual incidence rates of idiopathic DCM in adult/heterogeneous populations ranged from 6.0 to 7.0 per 100,000 persons. Annual incidence of DCM due to idiopathic/non-idiopathic causes among pediatric populations was reported as 0.6 per 100,000 persons. Reported prevalence and incidence rates by sex showed male preponderance, and estimates were higher in Black persons compared with White and Hispanic persons; higher DCM prevalence estimates were observed in studies utilizing newer DCM definitions using ICD coding compared with older definitions.
This study highlights the varied prevalence and incidence rates of DCM reported across different geographic locations, time periods, sexes, races, and disease definitions. When comparing these rates, it is crucial to consider factors such as data sources, case definitions, case-finding methodologies, and study populations.
扩张型心肌病(DCM)是全球心力衰竭和心脏移植的主要促成因素。估计DCM的患病率和发病率对于了解这些患者的疾病负担以及改善预防性治疗的前景至关重要。先前的综述显示,在美国和几个欧洲国家等关键地区,DCM的患病率和发病率估计数相当可观。本综述旨在描述美国、法国、德国、意大利、西班牙和英国已发表的关于DCM患病率和发病率的证据。
对MEDLINE和Embase数据库从创建到2023年5月9日进行检索,以查找报告目标国家成人或儿童普通人群中DCM患病率或发病率的英文研究。还对手工检索相关会议以及先前文献综述的参考文献。
在6145篇已识别的文章中,有10项独特的研究被纳入本综述。6项研究报告了患病率,5项研究报告了不同人群中DCM的发病率。成人(≥18岁)和/或异质人群(所有年龄段)中包括特发性和非特发性病因的DCM患病率估计为每10万人42.8至118.3例;特发性DCM估计为每10万人8.3至59.2例。青少年(约11 - 18岁)DCM(包括特发性和非特发性病因)的患病率为每10万人2.6至212.8例。成人/异质人群中特发性DCM的年发病率为每10万人6.0至7.0例。据报告,儿科人群中特发性/非特发性病因导致的DCM年发病率为每10万人0.6例。按性别报告的患病率和发病率显示男性占优势,黑人的估计数高于白人和西班牙裔;与旧定义相比,使用ICD编码的新DCM定义的研究中观察到更高的DCM患病率估计数。
本研究强调了不同地理位置、时间段、性别、种族和疾病定义下报告的DCM患病率和发病率各不相同。在比较这些比率时,考虑数据来源、病例定义、病例发现方法和研究人群等因素至关重要。